MG-2119
MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. MG-2119 is a potential agent for neurological disorders research[1].
Product Specifications
CAS Number
1065500-40-4
UNSPSC
12352005
Target
Tau Protein
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mg-2119.html
Concentration
10mM
Purity
99.67
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(NC(COC)=O)=CC2=C1N(CCC3=CC=CC=C3)C=N2)NCC(C)OC4=CC=CN=C4
Molecular Formula
C27H29N5O4
Molecular Weight
487.55
References & Citations
[1]Gabr MT, et al. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11 (14) :2051-2057.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942432-500 1x 500 µL
BAP1 (BRCA1 Associated Protein 1) (BAP1/2432), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942746-100 1x 100 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
